# ALNY: Alnylam Pharmaceuticals, Inc.

- Industry: Pharmaceutical Preparations
- Current price: $239.56
- Price updated: Sep 19, 2026
- Total congressional trades: 2
- Politicians trading: 2
- Last traded: Aug 11, 2026
- Source: https://tryglasshouse.ai/companies/ALNY.md

Alnylam Pharmaceuticals is a leader in the study of RNA interference (RNAi) therapeutics. RNAi is a naturally occurring biological pathway in cells that enables sequence-specific silencing and regulation of gene expression. Alnylam has five drugs on the market: Onpattro and Amvuttra for hATTR amyloidosis, Givlaari for acute hepatic porphyria, Oxlumo for primary hyperoxaluria type 1, and Leqvio for hypercholesterolemia. It also has several clinical programs across various therapeutic areas: genetic medicines; cardio-metabolic diseases; hepatic infectious diseases, and CNS/ocular diseases. Upfront fees from research partnerships have boosted Alnylam's cash levels, and the company stands to see additional milestones and royalties from drugs commercialized under collaboration partnerships.

# Congressional trading history

- Page: 1 of 1
- Results: 2 of 2
- Pagination query parameter: `page`

## 1. Cory A. Booker

- Member: Democrat, Senate
- Transaction: Sell, $1,001 - $15,000
- Dates: traded Aug 11, 2026, disclosed Sep 9, 2026
- Market context: $221.2 at trade, $239.56 current (+8.30%)
- Politician: https://tryglasshouse.ai/politicians/B001288.md
- Record: https://tryglasshouse.ai/trades/a30f0166-ef35-46b8-9ba0-dc25c8b8a6d1.md

## 2. Jefferson Shreve

- Member: Republican, House
- Transaction: Sell, $15,001 - $50,000
- Dates: traded May 12, 2025, disclosed Jun 22, 2025
- Market context: $270.19 at trade, $239.56 current (-11.34%)
- Politician: https://tryglasshouse.ai/politicians/S001229.md
- Record: https://tryglasshouse.ai/trades/d8ce2aef-bb4c-440b-bc05-cd5fd5d90926.md



Prices and percentage changes are market context, not portfolio returns. This information is not financial advice.